T cell hypo-responsiveness against Leishmania major in MAP kinase phosphatase (MKP) 2 deficient C57BL/6 mice does not alter the healer disease phenotype by Schroeder, Juliane et al.
Strathprints Institutional Repository
Schroeder, Juliane and McGachy, H Adrienne and Woods, Stuart and 
Plevin, Robin and Alexander, James (2013) T cell hypo-responsiveness 
against Leishmania major in MAP kinase phosphatase (MKP) 2 deficient 
C57BL/6 mice does not alter the healer disease phenotype. PLOS 
Neglected Tropical Diseases, 7 (2). , 
http://dx.doi.org/10.1371/journal.pntd.0002064
This version is available at http://strathprints.strath.ac.uk/43220/
Strathprints is  designed  to  allow  users  to  access  the  research  output  of  the  University  of 
Strathclyde. Unless otherwise explicitly stated on the manuscript, Copyright © and Moral Rights 
for the papers on this site are retained by the individual authors and/or other copyright owners. 
Please check the manuscript for details of any other licences that may have been applied. You 
may  not  engage  in  further  distribution  of  the  material  for  any  profitmaking  activities  or  any 
commercial gain. You may freely distribute both the url (http://strathprints.strath.ac.uk/) and the 
content of this paper for research or private study, educational, or not-for-profit purposes without 
prior permission or charge. 
Any  correspondence  concerning  this  service  should  be  sent  to  Strathprints  administrator: 
strathprints@strath.ac.uk
T Cell Hypo-Responsiveness against Leishmania major in
MAP Kinase Phosphatase (MKP) 2 Deficient C57BL/6 Mice
Does Not Alter the Healer Disease Phenotype
Juliane Schroeder*, H. Adrienne McGachy, Stuart Woods, Robin Plevin, James Alexander
Strathclyde Institute for Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom
Abstract
We have recently demonstrated that MAP kinase phosphatase 2 (MKP-2) deficient C57BL/6 mice, unlike their wild-type
counterparts, are unable to control infection with the protozoan parasite Leishmania mexicana. Increased susceptibility was
associated with elevated Arginase-1 levels and reduced iNOS activity in macrophages as well as a diminished TH1 response.
By contrast, in the present study footpad infection of MKP-22/2 mice with L. major resulted in a healing response as
measured by lesion size and parasite numbers similar to infected MKP-2+/+ mice. Analysis of immune responses following
infection demonstrated a reduced TH1 response in MKP-2
2/2 mice with lower parasite specific serum IgG2b levels, a lower
frequency of IFN-c and TNF-a producing CD4+ and CD8+ T cells and lower antigen stimulated spleen cell IFN-c production
than their wild-type counterparts. However, infected MKP-22/2 mice also had similarly reduced levels of antigen induced
spleen and lymph node cell IL-4 production compared with MKP-2+/+ mice as well as reduced levels of parasite-specific IgG1
in the serum, indicating a general T cell hypo-responsiveness. Consequently the overall TH1/TH2 balance was unaltered in
MKP-22/2 compared with wild-type mice. Although non-stimulated MKP-22/2 macrophages were more permissive to L.
major growth than macrophages from MKP-2+/+ mice, reflecting their reduced iNOS and increased Arginase-1 expression,
LPS/IFN-c activation was equally effective at controlling parasite growth in MKP-22/2 and MKP-2+/+ macrophages.
Consequently, in the absence of any switch in the TH1/TH2 balance in MKP-2
2/2 mice, no significant change in disease
phenotype was observed.
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Introduction
Leishmania species are protozoan parasites that are transmitted
by infected female sandflies and cause a wide spectrum of diseases
ranging from self-healing cutaneous lesions to fatal systemic
disease. After entering their vertebrate host, promastigotes are
taken up initially by neutrophils and ultimately macrophages and
dendritic cells, where they turn rapidly into amastigotes and
survive within parasitophorous vacuoles [1]. Resistance against
cutaneous infection with Leishmania (L.) major typically requires the
presence of an antigen-specific type 1 immune response compris-
ing of IFN-c/TNF-a/IL-2 producing CD4+ T [2,3] cells but also
CD8+ T cells have been shown to play an important role in
parasite clearance [4,5]. Subsequently, activated T cells migrate to
the site of infection where they release IFN-c and TNF-a which in
turn upregulate inducible nitric oxide synthase (iNOS) in infected
macrophages, enabling nitric oxide (NO) mediated killing of the
intracellular parasites [6,7]. Susceptibility, on the other hand, has
been associated with a failure to produce a type-1 response, which
may be a consequence of IL-10 production from Fc-c mediated
macrophage uptake of amastigotes [8], or from natural and or
type-1 regulatory T cells [9–11], or regulatory B cells [12], or an
elevated TH2 response and the excessive production of IL-4 by
CD4+ T cells [2,13], or indeed a combination of all these factors
(reviewed by [14]). IL-4 in particular has been shown to promote
alternative macrophage activation including increased expression
of Arginase-1 [15], suppression of iNOS [16] and increased
growth of L. major.
Mitogen-activated protein kinase phosphatase 2 (MKP-2) is a
dual-specific nuclear phosphatase (DUSP) and is associated with
the MAPK signalling pathway, where it has been shown to
dephosphorylate and thereby inactivate protein kinases ERK,
JNK but not p38 in vitro [17,18]. MKP-2 could therefore have
significant effects on L. major infection as these parasites have a well
recognized ability to subvert the development of TH1 responses
partly via effects upon MAP kinase signalling. Studies using L.
major metacyclic promastigotes indicated that the parasite via
lipophosphoglycan (LPG) differentially regulated IL-12 as well as
NO production by targeting ERK and p38 MAPK, respectively
[19,20]. In order to better understand the role of MKP-2 in
immune functions we, and others, have recently created MKP-2
deficient mice on a C57BL/6 background [21–24]. Thus
regulatory roles specific for MKP-2 have been demonstrated in
the inflammatory response associated with sepsis [22], cell cycle
progression and apoptosis [23] and infection [21]. Furthermore,
MKP-22/2 macrophages have severe ablation of LPS or IFN-c -
PLOS Neglected Tropical Diseases | www.plosntds.org 1 February 2013 | Volume 7 | Issue 2 | e2064
induced iNOS expression and nitric oxide release and enhanced
basal expression of Arginase-1. Given that Arginase-1 competes
with iNOS for their common substrate L-arginine, it suggested
that MKP-2 could have a regulatory function significant in
immune responses involving intracellular pathogens [25]. Indeed,
following infection with the intracellular parasite L. mexicana we
demonstrated that it was changes in Arginase-1 and iNOS rather
than changes in kinase mediated signalling that dictated the
subsequent in vivo response to MKP-2 deletion [21]. MKP-22/2
mice displayed increased lesion size and parasite burden, and a
significantly modified TH1/TH2 bias compared with wild-type
counterparts [21]. This was related to a significant down-
regulation of specific TH1 activity in MKP-2 deficient animals.
However, there was no intrinsic defect in MKP-22/2 T cell
function as measured by anti-CD3 induced IFN-c production.
Rather, MKP-22/2 bone marrow-derived macrophages, as a
consequence of increased Arginase-1 expression, were found to be
inherently more susceptible to infection with L. mexicana than
MKP-2+/+ derived macrophages.
The immune-regulatory mechanisms controlling L. mexicana and
L. major differ significantly and while most mouse strains heal
following infection with L. major the vast majority develop chronic
infections following infection with L. mexicana (reviewed by [26]).
Thus, while C57BL/6 mice can control L. mexicana lesion growth
they do not cure and MKP-2 deficiency results in progressive
disease following L. mexicana infection [21]. C57BL/6 mice on the
other hand are more resistant to L. major and lesions heal following
infection. Given the well documented importance of NO killing in
controlling L. major infections we addressed the question as to
whether MKP-2 deficiency would make C57BL/6 mice more
susceptible to this parasite. To our surprise no distinct disease
phenotype was noted in MKP-22/2 mice infected with this
parasite. Although type-1 responses in infected MKP-22/2 mice
were down-regulated, type-2 responses were equally suppressed
and the TH1/TH2 balance remained unaffected. Furthermore
although MKP-22/2 naı¨ve macrophages were more permissive
host cells for L. major than wild-type macrophages, if classically
activated they were equally effective at controlling parasite growth.
Materials and Methods
Ethics statement
Female DUSP-4 (MKP-2) wild-type and deficient mice were
generated as previously described and bred onto C57BL/6
background [21] and female BALB/c mice were bred and
maintained under specific pathogen-free conditions in the animal
facilities of the Strathclyde Institute for Pharmacy and Biomedical
Sciences at the University of Strathclyde. Animals were used at 6–
9 weeks of age and were age matched within each experiment. All
animal experiments adhered to the UK Animals (Scientific
Procedures) Act 1986 and were conducted under Project Licenses
to RP (PPL60/3439 ‘‘genetic models of cancer and inflamma-
tion’’) and JA (PPL60/3929 ‘‘mechanism of control of parasite
infection’’) granted by the UK Home Office and with local ethical
approval.
Parasite infections
Leishmania major (IR75) promastigotes were grown in HOMEM
(Gibco) supplemented with 10% FCS (Biosera, East Sussex, UK)
until late stationary phase. In order to enable direct comparison
with previous studies on the role of MKP-2 during L. mexicana
infections [21] and to Arginase-1/L. major studies [27,28] relevant
to the work presented here we used the high dose inoculation
model. Mice were given 26106 L. major subcutaneously into the
left hind foot pad and lesion development was monitored as the
difference in thickness between infected and uninfected foot pads
using a dial gauge calliper. For determination of parasite burden,
mice were sacrificed by cerebral dislocation and foot pads,
popliteal lymph nodes and spleens were removed and homoge-
nized. Single cell suspensions were adjusted to equal volumes and
subjected to limiting dilution assay as described elsewhere [29].
T cell assay
Single cell suspensions from spleens and lymph nodes of infected
mice were prepared and erythrocytes were lysed using Erythrocyte
lysis buffer pH 7.3 (160 mM NH4Cl, 10 mM KHCO3 and
100 mM EDTA). Cells were resuspended in RPMI containing
10% FCS, L-Glutamine and Penicillin/Streptomycin and 26106
splenocytes were restimulated either on dendritic cells pulsed with
5 mg L. major antigen over night, PMA (10 ng/ml)/Ionomycin
(500 ng/ml), ConA (10 mg/ml) or medium alone for 6 h
(intracellular staining) or 48–72 h (ELISA) in 24-well plates. For
intracellular staining, cytokine release was inhibited by the
addition of BrefeldinA (10 mg/ml) at 3 h into re-stimulation. All
reagents were supplied by Sigma-Aldrich (St. Louis, USA).
Magnet assisted cell sorting (MACS)
CD4+ T cells from spleens and lymph nodes of infected mice
were isolated on LS magnetic columns (Miltenyi Biotec GmbH,
Bergisch Gladbach, Germany) using the negative selection kit
(Miltenyi) following manufacturer’s instructions.
Enzyme linked immunosorbant assay (ELISA)
Mouse serum was analysed individually for antigen-specific
IgG1 or IgG2b using single sided ELISA as previously described
[30]. Resulting titres were expressed as reciprocal values of the
half-maximal absorption at 450 nm using a Spectromax 190 plate
reader.
Cytokines from T cell supernatants were determined with
Sandwich-ELISA using cytokine specific capture and detection
Author Summary
Leishmania species are parasites that are of extensive
public health importance in the tropics and subtropics.
Within humans the parasites are intracellular and reside
particularly within macrophages. Classical activation of
macrophages by Interferon-c (IFN-c) induces the enzyme
nitric oxide synthase (iNOS) and parasites are killed via the
production of nitric oxide (NO) from the substrate L-
arginine. Alternative activation by Interleukin-4 (IL-4)
results in Arginase-1 expression, which depletes L-arginine
and facilitates parasite growth. We have recently shown
that MAP Kinase Phosphatase-2 (MKP-2) suppresses
macrophage Arginase-1 and that C57BL/6 mice with a
deletion of this gene are subsequently extremely suscep-
tible to New World cutaneous leishmaniasis caused by
Leishmania mexicana. Surprisingly, MKP-2 deficient mice
have been shown here to be resistant to Old World
cutaneous leishmaniasis caused by L. major. We show that
during infection with L. major, enhanced Arginase-1 in
MKP-2 deficient mice serves to induce a generalized T cell
hypo-responsiveness so that IFN-c and IL-4 levels are
equally suppressed compared with intact mice. In addition,
unlike L. mexicana, classically activated MKP-2 deficient
macrophages were able to control L. major growth equally
as well as MKP-2 intact macrophages, highlighting a
fundamental difference in the control of these two species.
MKP-2 Deletion in Leishmania major Infection
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antibodies (BD Bioscience) and recombinant cytokines for
standard curves (R&D Systems, Minneapolis, USA). IL-4 was
determined using the mouse IL-4 Quantikine kit (R&D Systems)
following manufacturer’s instructions. To allow detection of IL-4,
5 mg/ml IL-4 receptor blocking antibody (anti-mouse CD124, BD
Pharmingen, USA) was added to the cultures.
Flow cytometry
Cells were harvested and passed through a nitex mesh to remove
clumps. For isotype control, 56105 cells of medium-, antigen- and
PMA/Ionomycin-restimulated splenocytes were pooled for each
individual. After blocking unspecific binding with 10% mouse
serum and Fc receptor blocking antibodies (anti-mouse CD16/32,
eBioscience, UK), cell surface was stained with conjugated
antibodies for CD3e (PerCP), CD4 (APC-H7), both BD Pharmin-
gen (USA) and CD8b (Alexa Fluor 488, eBioscience UK) for 45 min
at 4uC. Cells were fixed for 15 min and permeabilized using the Fix
and Perm kit (Invitrogen, Paisley, UK). Intracellular staining was
carried out simultaneously with permeabilisation for 1 h at room
temperature using conjugated antibodies for IFN-c (Allophycocya-
nin (APC)) and TNF-a (Phycoerythrin (PE)) or their respective
isotypes anti-rat IgG1 (APC) and anti-rat IgG1 (PE), all eBioscience.
After washing steps, cells were resuspended in 200 ml PBS and
subsequently run and analysed on the FACS Canto flow cytometer
(BD Bioscience) using FACS Diva software.
Cell culture
Bone marrow-derived macrophages (BMDM) and dendritic cells
were derived from tibia and femur of 6 to 8 week old mice. Bone
marrow was flushed, and in order to obtain macrophages, cells were
resuspended in DMEM containing 10% foetal calf serum (FCS),
30% L929-conditioned medium, 2 mM L-Glutamine (Gibco,
Invitrogen, Paisley, UK), 1% Penicillin/Streptomycin (Gibco) and
seeded into Petri dishes. After 10 days at 37uC, adherent
macrophages were harvested with cold/warm PBS, washed and
resuspended in complete RPMI (10% FCS, 2 mM L-Glutamine,
1% Penicillin/Streptomycin). Dendritic cells were generated from
bone marrow precursors by culturing in RPMI containing 10%
FCS, 2 mM L-Glutamine, 1% Penicillin/Streptomycin and 2.5–
10%GM-CSF conditioned medium (X63). Non-adherent cells were
harvested at day 7, washed and resuspended in complete RPMI.
Macrophage infections
BMDMs were seeded onto cover slips at 26105 cells/500 ml in
24-well plates and left to adhere at 37uC over night. For infection
L. major promastigotes (IR75) were added at a multiplicity of
infection (MOI) of 5 and plates were briefly spun at 3006g to
allow close proximity of parasite and macrophages. After 1 h at
34uC, supernatants were removed and macrophages were washed
in PBS to remove any free parasites. Fresh complete RPMI
supplemented with or without 100 ng/ml LPS, 100 U/ml IFN-c
or 100 U/ml IL-4 was added and cells were incubated at 34uC for
different periods of time.
To determine number of parasites and infection rates,
macrophages were fixed in methanol and stained with Giemsa
solution. Cover slips were mounted onto glass slides and
intracellular parasites were counted in a total of 200 macrophages
across each cover slip using a bright field microscope.
Immunoblotting
Arginase-1 expression was determined from whole cell lysates of
16106 L. major-infected BMDM. SDS-PAGE analysis and
detection was carried out as described elsewhere [21].
Statistics
Statistical analysis was performed using GraphPad Prism
Program (Version 4.0, GraphPad Software, San Diego, Califor-
nia). P values below or equal to 0.05 were considered significant.
Results
MKP-2 deficiency in C57BL/6 mice did not alter the
course of infection with L. major
MKP-2 deficient and MKP-2 wild-type C57BL/6 mice were
given 26106 late-stationary phase L. major promastigotes subcu-
taneously into the left hind footpad and lesion development was
monitored over 12–13 weeks. Surprisingly, given that MKP-22/2
mice were previously found to be more susceptible to L. mexicana
than their wild-type counterparts [21], no difference in lesion
growth between MKP-22/2 and MKP-2+/+ mice was detected
throughout the course of infection with L. major. Both MKP-22/2
and MKP-2+/+ mice developed lesions which healed spontane-
ously after several weeks and in a manner typical for L. major
resistant C57BL/6 mice (Figure 1A). At two time points, the peak
of infection (Figure 1B) and after onset of healing (Figure 1C), five
mice were sacrificed and the parasite burdens of infected footpads,
popliteal draining lymph nodes and spleens were determined.
Consistent with the lesion development, parasite numbers were
high at the peak of infection and consequently dropped with the
onset of healing. We could not observe a difference in phenotype
between wild-type and MKP-22/2 mice at either peak lesion
growth or after healing in any of the tissues examined. This
observation was made in several independent experiments.
Enhanced susceptibility of MKP-22/2 macrophages to
infection with L. major is ablated following classical but
not innate or alternative activation
Our previous studies demonstrated that the susceptibility of
MKP-2 deficient mice is to a significant degree due to MKP-22/2
macrophages being inherently more susceptible to the growth of L.
mexicana than wild-type macrophages a dichotomy that was
maintained even following classical activation [21]. We therefore
examined the infectivity of L. major metacyclic promastigotes for
MKP-22/2 and MKP-2+/+ naı¨ve, innately, classically or alterna-
tively activated bone marrow derived macrophages (Figure 2 A, B
and C). Over several experiments we found that infected non-
stimulated MKP-22/2 BMDM cultures maintained significantly
increased parasite burdens and increased frequency of infected
macrophages than cultures using their wild-type counterparts
(Figure 2A). Our previous studies with L. mexicana had demon-
strated the increased susceptibility of non-stimulated MKP-22/2
macrophages to infection to be related to elevated Arginase-1
levels compared with MKP-2+/+ macrophages and similarly
enhanced levels of Arginase-1 were found in MKP-22/2
macrophages following infection with L. major promastigotes
(Figure 2E). Innate macrophage activation with 100 ng/ml LPS
greatly decreased the number of intracellular parasites as well as
the frequency of infected cells in both MKP-22/2 and MKP-2+/+
macrophages (Figure 2A). However, despite activation with LPS,
MKP-2 deficient macrophages still presented higher parasite
survival than their wild-type counterparts. As nitric oxide (NO) is
essential for killing of intracellular parasites, we determined the
production of NO by measuring nitrite levels in the supernatants
of infected macrophages 24 and 48 h after activation with LPS.
Consistent with our previous observations with L. mexicana, MKP-
22/2macrophages showed a reduced NO production at both time
points in response to LPS activation (Figure 2D). However,
MKP-2 Deletion in Leishmania major Infection
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whereas MKP-22/2 macrophages classically activated with LPS
and IFN-c failed to reduce L. mexicana parasite burdens to the level
of similarly treated MKP-2+/+ macrophages [21] such treatment
sufficed following infection with L. major promastigotes to ablate
any differences in susceptibility between MKP-22/2 and MKP-
2+/+ host cells (Figure 2B) and corresponded to LPS and IFN-c
treatment ablating the deficiency in NO production in MKP-22/2
macrophages infected with L. major (data not shown). The addition
of recombinant IL-4 to macrophages infected with L. major
doubled the numbers of intracellular parasites in both wild-type
and MKP-22/2 macrophages (Figure 2C), highlighting the
disease-promoting attributes of IL-4 and alternative macrophage
activation in L. major infections characterized by elevated Arginase-
1 and reduced iNOS expression [16,31].
MKP-2 deficiency results in a diminished TH1 response
following infection with L. major
As no discernible change in the healing disease phenotype was
observed between MKP-22/2 and MKP-2+/+ mice infected with
L. major, and given that classically activated macrophages from
MKP-22/2 mice were equally as effective as their wild-type
counterparts at killing parasites we compared the type-1 response
generated in MKP-2+/+ and MKP-22/2 following infection. After
re-stimulation with soluble L. major antigen-pulsed DCs, flow
cytometric analysis of CD4+ T cells from the spleens of infected
animals demonstrated that MKP-22/2 mice had a significantly
lower frequency of IFN-c single producing and IFN-c/TNF-a
double producing CD4+ and CD8+ T cells (P,0.05) than their
wild-type counterparts (Figure 3A, B and C). Similarly significantly
reduced IFN-c production (P,0.05) was measured in the
supernatants of MKP-22/2 derived T cell cultures after stimula-
tion with L. major antigen-pulsed DC, PMA/Ionomycin or ConA
(Figure 3D). Finally we analysed the serum of L. major infected
mice for the presence of antigen-specific IgG2b, a surrogate
marker for TH1 responses, as IFN-c is essential for IgG class switch
to 2a and 2b [32,33]. At both stages of infection, MKP-2 deficient
mice showed lower IgG2b titres, being statistical significant
(P,0.05) at day 42 post-infection (Figure 3E). Overall, our data
suggest that MKP-2 deficiency results in a diminished TH1
response during infection with L. major, similar to our previous
observations using L. mexicana infections [21].
MKP-2 deficiency results in a reduced TH2 response in L.
major infected mice
In stark contrast to experimental infection with L. mexicana,
MKP-2 deficient mice did not show an increased susceptibility to
infections with L. major compared with wild-type mice. This was
despite a clearly diminished TH1 response in MKP-2
2/2
compared with MKP-2+/+ mice following L. major infection
(Figure 3). However, MKP-2 is a generalized negative regulator
Figure 1. MKP-2 deficiency does not alter the course of infection with L. major. Ten MKP-22/2 (open symbols) and ten MKP-2+/+ mice
(closed symbols) were given with 26106 L. major promastigotes subcutaneously into the left hind foot pad. The right uninfected foot pad was used
for reference. Lesion development was monitored by measuring the footpad thickness (A) over time using a dial gauge calliper. At peak of infection
(day 42, B) and after the onset of healing (day 88, C) five mice were sacrificed at random and parasite burdens in foot pad, popliteal lymph nodes and
spleens were determined using a limiting dilution assay. Detection limit was 65 for spleens and 6500 for lymph node and foot pads. Error bars are
shown as standard error of the mean (SEM). The data shown is representative of at least three independent experiments.
doi:10.1371/journal.pntd.0002064.g001
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of Arginase-1in tissues rich in phagocytes (Figure S1) and it is well
documented that Arginase-1 can induce hypo-responsiveness in a
pan-T cell fashion [27,28] [34]. We therefore examined whether
the lack of a parasite-specific TH1 response could be counterbal-
anced by concomitant impairment of a TH2 response, leaving the
relative TH1/TH2 balance undisturbed. Over a number of
experiments we found MKP-22/2 mice infected with L. major
produced less IgG1 but not significantly less than their similarly
infected wild-type counterparts (Figure 4A). To directly measure
the parasite induced production of IL-4, we infected MKP-2 wild-
type and deficient mice as well as susceptible BALB/c mice with L.
major promastigotes. At the peak of infection, mice were sacrificed,
spleens and draining lymph nodes removed and analyzed for the
production of IL-4. Whole spleen and lymph node cells were re-
stimulated with soluble L. major antigen-pulsed DC, PMA/
Ionomycin or ConA for 72 h in the presence of IL-4 receptor
blocking antibody to prevent immediate uptake of freshly
produced IL-4 in an auto- or paracrine fashion. As expected,
susceptible BALB/c mice produced high levels of IL-4 compared
with mice from the C57BL/6 background (Figure 4B). However,
while antigen induced IL-4 production was reduced in MKP-22/2
splenocytes and draining lymph node cells (Figure 4C and D)
compared with wild-type equivalent cell populations this was not
clearly significant because of small sample sizes. For a more precise
examination of the TH2 response we therefore isolated CD4
+ T
cells from spleen suspensions by negative selection and re-
stimulated these as described above. The levels of IL-4 produced
by CD4+ T cells in response to L. major infection were indeed
clearly and significantly reduced in MKP-2 deficient mice when
compared with wild-type mice (Figure 4E), thus confirming a
reduced TH2 response in infected MKP-2
2/2 mice.
The TH1/TH2 balance in MKP-2 deficient mice compared
with wild type mice is sustained by general T cell hypo-
responsiveness against L. major
Previous studies have suggested that it is not the quantity of
IFN-c or IL-4 production that is important in determining
Figure 2. Macrophages of MKP-22/2 mice are inherently more susceptible to L. major parasites. Bone marrow-derived macrophages of
MKP-22/2 (open symbols) and MKP-2+/+ (closed symbols) grown on cover slips were infected with L. major promastigotes at a multiplicity of infection
(MOI) of 5. One hour after infection free parasites were removed by washing and medium was replaced with complete RPMI supplemented with or
without 100 ng/ml LPS or a combination of 100 ng/ml LPS and 100 U/ml IFN-c, or 100 U/ml IL-4 and left for 24 or 48 h at 34uC (A, B and C
respectively). Macrophages were fixed in methanol and stained with Giemsa. Intracellular parasites were counted in a total of 200 macrophages using
a bright field microscope and are shown as number of parasites per 100 macrophages. The mean percentage of infected macrophages is also
expressed as numbers inside the columns. At time points indicated supernatants from LPS-stimulated macrophages were removed and tested for
nitric oxide production using Griess reagent (D). Error bars show standard error of the mean (SEM). The data shown is representative of at least three
independent experiments. For analysis of Arginase-1 expression 16106 BMDM were infected at an MOI of 5 and whole cell lysates were run on 12%
gels, blotted on nitrocellulose membranes and stained for Arginase-1. The top cross-reactive band serves as loading control (E).
doi:10.1371/journal.pntd.0002064.g002
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Figure 3. MKP-2 deficient mice infected with L. major have a reduced TH1 response. Splenocytes from L. major infected MKP-2
2/2 (open
columns) and MKP-2+/+ (closed columns) mice were re-stimulated either with antigen pulsed DC, PMA/Ionomycin, ConA or with unpulsed DC
(Medium control) for 6 h (FACS) or 48 h (ELISA). Cells were stained for T cell surface markers CD3, CD4 and CD8 as well as intracellular cytokines IFN-c
and TNF-a or their respective isotypes (A). Percentages of IFN-c single and IFN-c/TNF-a double producing parasite-specific CD4+ (B) and CD8+ (C) T
cells are shown after normalization to medium and isotype controls. Supernatants of 48 h T cell re-stimulations were analyzed for IFN-c in a sandwich
ELISA and values were normalized to medium controls (D). Serum of infected mice was collected and analysed for parasite-specific antibody isotype
IgG2b. The titres were calculated as reciprocal dilution of the half-maximal absorption at 450 nm (E). Error bars are shown as standard error of the
mean (SEM). *P,0.05, **P,0.01; one-tailed Mann Whitney U test. The data shown is representative of two independent experiments.
doi:10.1371/journal.pntd.0002064.g003
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protective immunity to L. major but rather the overall TH1/TH2
balance [35,36]. Consequently we calculated the relative TH1/
TH2 balance between L. major infected MKP-2
2/2 and MKP-2+/+
mice. In the first instance we calculated the ratio of IgG2b to IgG1
for each individual mouse, as this is a strong indicator of TH1/TH2
balance [37–39]. However no difference in IgG2b/IgG1 levels
between L. major infected MKP-22/2 and MKP-2+/+ mice were
observed throughout infection (Figure 5A). Not surprisingly, the
ratio increased after onset of healing toward an IgG2b bias and
thus a TH1 response in both MKP-2
2/2 and MKP-2+/+ mice. We
further calculated the percentage reduction in the levels of type-1
and type-2 cytokine responses induced in MKP-22/2 compared
with wild-type mice following infection. MKP-22/2 splenocytes
from L. major infected mice produced, upon restimulation with L.
major antigen-pulsed DCs, 32.6% less IFN-c (Figure 5B) than
MKP-2+/+ splenocytes (20.7965.53 (SD) and 30.8765.39 (SD)
ng/ml, respectively). Under the same experimental conditions a
37.8% reduction in IL-4 production (Figure 5B) was generated by
Figure 4. MKP-2 deficient mice infected with L. major have a reduced TH2 response. Serum of L. major infected MKP-2
2/2 (open column)
and MKP-2+/+ (closed column) mice was analysed for parasite-specific antibody isotype IgG1 (A). The titres were calculated as reciprocal dilution of
the half-maximal absorption at 450 nm. In order to measure TH2 responses, 3 MKP-2
2/2, 3 MKP-2+/+ and 3 BALB/c mice were given 26106 L. major
promastigotes subcutanteously into the hind foot pad. At peak of infection, mice were sacrificed and spleen and popliteal lymph node removed.
Spleens were analysed individually and lymph nodes pooled within each group. CD4+ T cells were magnet-purified from spleens using a negative
isolation kit. Splenocytes (B, C), lymph node cells (D) and purified CD4+ T cells (E) were re-stimulated either with antigen pulsed DC, PMA/Ionomycin,
or with unpulsed DC (Medium control) in the presence of IL-4 receptor blocking antibody for 72 h and supernatants were analysed immediately for
IL-4. Error bars show standard error of the mean (SEM). *P,0.05 one-tailed unpaired t test.
doi:10.1371/journal.pntd.0002064.g004
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MKP-22/2 splenocytes compared with MKP-2+/+ splenocytes
(35.4669.32 (SD) pg/ml compared with 56.99612.13 (SD) pg/
ml, respectively). Moreover, when comparing the percentage of
IFN-c/TNF-a double producing CD4+ T cells, as measured by
flow cytometry, we found a 28.7% reduction (Figure 5B) in
infected MKP-22/2 compared with MKP-2+/+ mice. Thus MKP-
2 deficiency results in a T cell hypo-responsiveness following L.
major infection, which effects both the protective TH1 and the
disease-exacerbating TH2 response to a similar degree (Figure 5C).
Consequently, MKP-22/2 mice have a healing phenotype similar
to their wild-type counterparts.
Discussion
In a previous study we identified a major role for MKP-2 in
protecting C57BL/6 mice from infection with L. mexicana as MKP-
2 deficiency resulted in uncontrolled lesion growth with massively
increased parasite burdens [21]. Increased susceptibility was
associated with MKP-22/2 macrophages being inherently more
susceptible than wild-type macrophages to parasite infection as a
result of increased Arginase-1 expression and also reduced NO
production [21]. In addition, while no specific direct defect in T
cell function could be attributed to MKP-2 deficiency, a
diminished parasite-specific TH1 and an enhanced TH2 response
developed in MKP-22/2 mice infected with L. mexicana [21].
Surprisingly therefore, in the present study, no differences
whatsoever in the normal healing phenotype were observed
between MKP-22/2 and MKP-2+/+ mice infected with L. major.
This was despite firstly, naı¨ve and innately activated MKP-22/2
macrophages being more permissive to L. major infection than
wild-type macrophages which, as with L. mexicana infections, was
associated with increased Arginase-1 and reduced iNOS activities,
and secondly, a clearly reduced parasite-specific TH1 response in
infected MKP-22/2 mice.
Infection of MKP-22/2 mice and their host cells with L. major
differed to that of infection with L. mexicana in two significant ways
that undoubtedly had profound effects on disease outcome. Firstly,
in contrast to infection with L. mexicana, infection of MKP-22/2
mice with L. major resulted not only in a reduced type-I response,
but also in an equally reduced TH2 response compared with wild-
type mice. Consequently there was no discernible difference in the
TH1/TH2 bias between MKP-2
2/2 and MKP-2+/+ mice infected
with this parasite. It is well established in C57BL/6 mice, that
once parasite peptide reactive-CD4+ and CD8+ T cell populations
reach the proper balance in draining lymph nodes and the sites of
infection, there is rapid healing, and immunity is maintained by a
persistent small amastigote population in equilibrium with both
effector and regulatory T cell populations [10,40]. Furthermore
studies in mice have demonstrated that the absolute amount of
IFN-c generated following infection with L. major did not correlate
with protection or cure [35,36] and rather, it was the balance in
the TH1/TH2 cytokine profile that was important in determining
disease outcome. Secondly, classically activated MKP-22/2
macrophages were equally as effective as MKP-2+/+ macrophages
in controlling the growth of L. major although not, as previously
demonstrated, L. mexicana [21]. Therefore, as the TH1/TH2
balance remained unaltered, albeit equally diminished, in L. major
infected MKP-22/2 compared with MKP-2+/+ mice, the com-
parative polarisation of classical macrophage activation would
remain the same. Consequently healing takes place in MKP-22/2
mice infected with L. major in a similar manner to infected resistant
wild-type mice.
Among the intriguing questions regarding the differential
outcome of L. major and L. mexicana infections in MKP-2 deficient
mice is why TH2 responses are maintained following L. mexicana
infection [21] but down-regulated following L. major infection
compared with their infected wild-type counterparts? It has been
demonstrated previously that during L. major infections high local
Arginase-1 levels at the site of infection mediate L-arginine
depletion, which results in impaired local CD4+ (and CD8+) T cell
function, particularly IFN-c production but also to a lesser extent
IL-4 and IL-10 [28,41]. Investigations carried out by Kropf et al.
[34] using Arginase-1 expressing placenta cells and Jurkat T cells
showed that Arginase-1-mediated T cell hypo-responsiveness is a
consequence of the down-regulation of the CD3f chain, a crucial
signal transducing component of the TCR [34] and significantly
Figure 5. A sustained TH1/TH2 balance in MKP-2 deficient mice
is due to general T cell hypo-responsiveness against L. major.
Antibody titres for IgG2b were divided by respective titres for IgG1 for
each individual mouse and for both time points. Higher values are
indicative for higher IgG2b levels and lower values reflect a higher IgG1
response. The bar indicates the median of each group (A). The percent
reduction of the mean for each measured parameter (IFN-c, IL-4 and
IFN-c/TNF-a+ CD4+ T cells) of MKP-22/2 mice was calculated against the
mean values of MKP-2+/+ mice ( = 100%) (B). If both immune responses
(TH1, (IFN-c/TNF-a
+ CD4+ T cells and IFN-c) versus TH2 (IL-4) are reduced
to a similar extend (B), the balance between disease promoting TH2 and
the protective TH1 response is not disturbed. Since the mice are on a
C57BL/6 background the TH1 response will outweigh the TH2 response
and consequently result in a healing phenotype (C).
doi:10.1371/journal.pntd.0002064.g005
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CD3f has recently been found to be down-regulated on CD4+ and
CD8+ T cells along with increased Arginase-1 activity in the
lesions of patients infected with L. aethiopica [42]. Depletion of L-
arginine, as a result of the generalised elevated Arginase-1 levels in
MKP-22/2 mice would explain the general T cell hypo-
responsiveness observed in these mice following infection with L.
major. However, why should the TH2 response be maintained if not
enhanced following infection of MKP-22/2 mice with L. mexicana
[21]? Studies to date clearly implicate the multiple CPB
isoenzymes as important species-specific virulence factors for the
L. mexicana complex and provide one possible explanation as to
why these parasites, unlike L. major (reviewed by [43]) tend to
induce chronic lesions in the majority of mouse strains such as the
C57BL/6 strain used in this study. Not only are L. mexicana CPBs
potent inhibitors of TH1 responses [44] as a consequence of
disrupting macrophage signalling pathways [45], but they have
also been shown to be potent inducers of IL-4 production and TH2
responses [46]. Consequently C57BL/6 mice infected with L.
mexicana CPB null mutants, unlike infection with wild-type
parasites, develop a healing response with reduced IL-4 produc-
tion and TH2 responses along with elevated TH1 responses [47].
Thus, as a result of their highly expressed TH2 promoting and
TH1 inhibiting CPBs infection of MKP-2
2/2 mice with L.
mexicana, unlike infection with L. major, is able to rescue and
promote the TH2 component of the parasite specific T cell
response which is less subject to Arginase-1 induced hypo-
responsiveness than TH1 responses [27].
Alternative activation of both MKP-22/2 and MKP-2+/+
macrophages resulted in increased susceptibility to L. major. This
would support the view that the TH1/TH2 balance is important
and that IL-4 and IFN-c activities regulate each other not just at
the T cell level but also at the level of the macrophage by
modulation of iNOS and Arginase-1 expression. In agreement IL-
4Ra signalling via macrophages/neutrophils has been shown to
promote early lesion growth in L. major infected BALB/c mice and
macrophage/neutrophil specific (LysMcreIL-4Ra2/lox) IL-4Ra2/
2 mice display delayed lesion growth [16]. The control of L. major
early in infection in LysMcreIL-4Ra2/lox mice has been identified
as being due to enhanced macrophage microbicidal NO mediated
activity in the absence of alternative macrophage activation.
Paradoxically we failed to identify any disease promoting
contributory role for IL-4Ra signalling via macrophages/neutro-
phils during L. mexicana infection [48]. In agreement in the present
studies we also failed to identify a disease promoting role for IL-4
in either MKP-22/2 or MKP-2+/+ macrophages infected with L.
mexicana (Figure S2). Thus the interaction of L. major and L.
mexicana with their host macrophages must be significantly
different. What may be critical in this regard is that L. amazonensis
parasites, which belong to the ‘‘mexicana’’ complex of parasites,
have been shown to be more resistant to macrophage-mediated
control than L. major requiring higher levels of NO to induce killing
[49,50]. The evidence would suggest that macrophage killing of
‘‘mexicana’’ complex parasites unlike L. major requires NO and
additionally, superoxide [51]. Furthermore, recent evidence
indicates that, unlike L. major, there is in fact enhanced replication
of the amastigote stage of L. amazonensis in IFN-c-stimulated
murine macrophages despite higher NO production [52],
reportedly due to the induction of a novel L-arginine pathway
independent of iNOS or host Arginase-1 [53]. Induction of
Arginase-1 by L. amazonensis has also been shown to enhance
replication of the amastigote stage of the parasite [52,53] while
inhibition studies have shown that the enhanced susceptibility of
MKP-22/2 macrophages for L. mexicana is associated with
enhanced Arginase-1 expression [21]. Thus given the relatively
higher sensitivity of L. major to NO matched with the increased
importance of Arginase-1 to infection with L. mexicana it is perhaps
not surprising that classical macrophage activation ablates MKP-2
deficiency mediated differences in infectivity with the former but
not the latter parasite.
Overall the present study confirms our previous observation
that MKP-2 is a major factor in determining the immune response
against intracellular parasites and potentially the outcome of
infection. Naı¨ve MKP-2 deficient macrophages are inherently
more susceptible to L. major than wild-type macrophages and
following infection there is a generalised T cell hypo-responsive-
ness. However, despite these apparent deficiencies the disease
phenotype of MKP-22/2 mice following L. major infection does
not differ from wild-type mice. Our results suggest that this is a
consequence of the TH1/TH2 balance remaining unaltered in
MKP-22/2 mice infected with L. major and that classical
macrophage activation suffices to ablate the innate permissiveness
of MKP-22/2 macrophages to this species.
Supporting Information
Figure S1 Arginase-1 levels are elevated in spleen and
intraperitoneal exudates of MKP-2 deficient mice. Equal
concentrations of whole cell lysates of intraperitoneal (IP)-washes
(left panel) and spleen (right panel) of three mice were run on 12%
gels, blotted on nitrocellulose membranes and stained for
Arginase-1. No Arginase-1 was detected in lymph nodes (not
shown). Samples were also run on 7.5% SDS gels, blotted and
stained for iNOS. However, iNOS could not be detected in any of
the samples (not shown).
(TIF)
Figure S2 External addition of IL-4 does not drastically
increase intracellular growth of L. mexicana. Bone
marrow-derived macrophages of MKP-22/2 (open columns) and
MKP-2+/+ (closed columns) mice grown on cover slips have been
infected with L. mexicana promastigotes at a multiplicity of infection
(MOI) of 5. One hour after infection free parasites have been
washed off and medium was replaced with complete RPMI
supplemented with or without 100 U/ml IL-4 and incubated for
48 h at 34uC. Macrophages were fixed in methanol and stained
with Giemsa. Intracellular parasites were counted in a total of 200
macrophages using a bright field microscope and are shown as
number of parasites per 100 macrophages. The mean percentage
of infected macrophages is also expressed as numbers inside the
graphs. Error bars show standard error of the mean (SEM).
(TIF)
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